New developments in fibroblast and myofibroblast biology: Implications for fibrosis and scleroderma

被引：128

作者：

Abraham D.J. ^{[1
]}

Eckes B. ^{[1
]}

Rajkumar V. ^{[1
]}

Krieg T. ^{[1
]}

机构：

[1] Department of Medicine, Royal Free and University College Medical School, University College London (Hampstead Campus), London NW3 2PF, Rowland Hill Street

来源：

Current Rheumatology Reports | 2007年 / 9卷 / 2期

关键词：

Scleroderma; Systemic Sclerosis; Connective Tissue Growth Factor; Cartilage Oligomeric Matrix Protein; Mesenchymal Cell Population;

D O I：

10.1007/s11926-007-0008-z

中图分类号：

学科分类号：

摘要：

The concept of mesenchymal fibroblasts has evolved over the past two decades from a relatively inert structural cell type to a dynamic, pluripotent cell lineage controlling normal connective tissue formation, homeostasis, and repair and as principle players in pathogenic scarring and fibrosis. In wound healing and tissue repair, fibroblasts provide proinflammatory signals and synthesize interstitial collagens, fibronectins, and other matrix components to repair the damaged tissue. Fibroblasts can differentiate into the myofibroblast, a specialized contractile cell type responsible for wound closure, tissue contraction, and scarring. This article reviews our current understanding of the origins of mesenchymal cells and their role in excessive scarring and fibrogenesis and in the systemic fibrotic disease scleroderma. Copyright © 2007 by Current Medicine Group LLC.

引用

页码：136 / 143

页数：7

共 55 条

[51]

Heldin C.H., Westermark B., Mechanism of action and in vivo role of platelet-derived growth factor, Physiol Rev, 79, pp. 1283-1316, (1999)

[52]

Shi-wen X., Pennington D., Holmes A., Et al., Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis, Exp Cell Res, 259, pp. 213-224, (2000)

[53]

Leask A., Abraham D.J., Finlay D.R., Et al., Dysregulation of transforming growth factor beta signaling in scleroderma: Overexpression of endoglin in cutaneous scleroderma fibroblasts, Arthritis Rheum, 46, pp. 1857-1865, (2002)

[54]

Whitfield M.L., Finlay D.R., Murray J.I., Et al., Systemic and cell type-specific gene expression patterns in scleroderma skin, Proc Natl Acad Sci U S A, 100, pp. 12319-12324, (2003)

[55]

Chen Y., Shi-wen X., van Beek J., Et al., Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: Insights into pathological scarring in chronic fibrotic disease, Am J Pathol, 167, pp. 1699-1711, (2005)

← 1 2 3 4 5 6 →